ACV isquémico asociado a inyección intravítrea de bevacizumab

: Given the current evidence, although there are no published reports from controlled clinical trials and therefore can not properly analyze their effectiveness and safety profile. Therefore should be administered only under conditions of protocol and informed consent. With particular caution in patients over 65 years as well as a history of artery disease.